{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T01:20:52Z","timestamp":1795224052938,"version":"4.10.3"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003482","name":"Science and Technology Project of the Department of Education of Hebei Province, China","doi-asserted-by":"publisher","award":["ZD202214"],"award-info":[{"award-number":["ZD202214"]}],"id":[{"id":"10.13039\/501100003482","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Enterprise-University-Research\u00b7Cooperation Project for Hebei-based Universities of Shijiazhuang Municipal Government","award":["241500417A"],"award-info":[{"award-number":["241500417A"]}]},{"name":"National Center of Technology Innovation for Pigs","award":["NTCIP-XD\/B11"],"award-info":[{"award-number":["NTCIP-XD\/B11"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Porcine epidemic diarrhea (PED), a highly contagious intestinal disease caused by PEDV, threatens newborn piglets and causes enormous losses in the swine industry. Intestinal mucosal immunity is vital for defense against PEDV. Chitosan (CS), a mucin-adhesive biodegradable polysaccharide, has emerged as a promising mucosal vaccine delivery vector and antigen adjuvant. To develop a PEDV mucosal vaccine, we prepared S1-CS nanoparticles (NPs) loaded with the S1 domain of the PEDV spike (S) protein. We evaluated their ability to induce mucosal immune responses in mice via different inoculation routes and to confer immune protection in piglets after oral inoculation. The results showed that S1-CS NPs exhibited no cytotoxicity and remained stable in simulated gastric fluid in vitro. Compared with oral administration, intramuscular inoculation of S1-CS NPs induced higher levels of PEDV-specific serum IgG in mice. However, PEDV-specific IgA was detected only in the serum and intestinal lavage fluid of orally vaccinated mice. Oral administration also elicited higher IFN-\u03b3 levels than intramuscular injection, suggesting stronger activation of cellular immunity. In piglets, oral S1-CS NPs induced serum neutralizing antibodies and IgA responses in both serum and intestinal mucosa, increased the number of IgA-secreting cells in the intestine, reduced viremia and virus shedding, and improved intestinal villus morphology. These findings indicate that the S1-CS NPs developed in this study represent promising candidates for an oral mucosal PEDV vaccine.<\/jats:p>","DOI":"10.1186\/s13567-025-01695-6","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T12:54:23Z","timestamp":1766148863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Intestinal mucosal immune responses induced by oral administration of chitosan nanoparticles encapsulating the PEDV S1 protein"],"prefix":"10.1186","volume":"57","author":[{"given":"Kai","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingli","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2899-8517","authenticated-orcid":false,"given":"Qinye","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"1695_CR1","doi-asserted-by":"crossref","first-page":"198045","DOI":"10.1016\/j.virusres.2020.198045","volume":"286","author":"K Jung","year":"2020","unstructured":"Jung K, Saif LJ, Wang Q (2020) Porcine epidemic diarrhea virus (PEDV): an update on etiology, transmission, pathogenesis, and prevention and control. Virus Res 286:198045\u2013198057","journal-title":"Virus Res"},{"key":"1695_CR2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.virusres.2016.09.003","volume":"226","author":"B Choudhury","year":"2016","unstructured":"Choudhury B, Dastjerdi A, Doyle N, Frossard JP, Steinbach F (2016) From the field to the lab - an European view on the global spread of PEDV. Virus Res 226:40\u201349","journal-title":"Virus Res"},{"key":"1695_CR3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12985-023-01961-z","volume":"20","author":"X Yao","year":"2023","unstructured":"Yao X, Qiao WT, Zhang YQ, Lu WH, Wang ZW, Li HX, Li JL (2023) A new PEDV strain CH\/HLJJS\/2022 can challenge current detection methods and vaccines. Virol J 20:13","journal-title":"Virol J"},{"key":"1695_CR4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.str.2020.12.003","volume":"29","author":"RN Kirchdoerfer","year":"2021","unstructured":"Kirchdoerfer RN, Bhandari M, Martini O, Sewall LM, Bangaru S, Yoon KJ, Ward AB (2021) Structure and immune recognition of the porcine epidemic diarrhea virus spike protein. Structure 29:385\u2013392","journal-title":"Structure"},{"key":"1695_CR5","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/mi.2012.37","volume":"5","author":"V Melkebeek","year":"2012","unstructured":"Melkebeek V, Rasschaert K, Bellot P, Tilleman K, Favoreel H, Deforce D, De Geest BG, Goddeeris BM, Cox E (2012) Targeting aminopeptidase N, a newly identified receptor for F4ac fimbriae, enhances the intestinal mucosal immune response. Mucosal Immunol 5:635\u2013645","journal-title":"Mucosal Immunol"},{"key":"1695_CR6","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1038\/s41598-019-39844-5","volume":"9","author":"CY Chang","year":"2019","unstructured":"Chang CY, Cheng IC, Chang YC, Tsai PS, Lai SY, Huang YL, Jeng CR, Pang VF, Chang HW (2019) Identification of neutralizing monoclonal antibodies targeting novel conformational epitopes of the porcine epidemic diarrhoea virus spike protein. Sci Rep 9:2529\u20132540","journal-title":"Sci Rep"},{"key":"1695_CR7","volume":"91","author":"C Li","year":"2017","unstructured":"Li C, Li W, de Lucio Esesarte E, Guo H, van den Elzen P, Aarts E, van den Born E, Rottier PJM, Bosch BJ (2017) Cell attachment domains of the porcine epidemic diarrhea virus spike protein are key targets of neutralizing antibodies. J Virol 91:e00273-17","journal-title":"J Virol"},{"key":"1695_CR8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3390\/v10090467","volume":"10","author":"T Suzuki","year":"2018","unstructured":"Suzuki T, Terada Y, Enjuanes L, Ohashi S, Kamitani W (2018) S1 subunit of spike protein from a current highly virulent porcine epidemic diarrhea virus is an important determinant of virulence in piglets. Viruses 10:467\u2013478","journal-title":"Viruses"},{"key":"1695_CR9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev-animal-022114-111038","volume":"3","author":"KS Chattha","year":"2015","unstructured":"Chattha KS, Roth JA, Saif LJ (2015) Strategies for design and application of enteric viral vaccines. Annu Rev Anim Biosci 3:375\u2013395","journal-title":"Annu Rev Anim Biosci"},{"key":"1695_CR10","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3389\/fimmu.2019.00727","volume":"10","author":"SN Langel","year":"2019","unstructured":"Langel SN, Paim FC, Alhamo MA, Buckley A, Van Geelen A, Lager KM, Vlasova AN, Saif LJ (2019) Stage of gestation at porcine epidemic diarrhea virus infection of pregnant swine impacts maternal immunity and lactogenic immune protection of neonatal suckling piglets. Front Immunol 10:727\u2013739","journal-title":"Front Immunol"},{"key":"1695_CR11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.it.2008.02.006","volume":"29","author":"R Pabst","year":"2008","unstructured":"Pabst R, Russell MW, Brandtzaeg P (2008) Tissue distribution of lymphocytes and plasma cells and the role of the gut. Trends Immunol 29:209\u2013219","journal-title":"Trends Immunol"},{"key":"1695_CR12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/mi.2012.4","volume":"5","author":"O Pabst","year":"2012","unstructured":"Pabst O, Mowat AM (2012) Oral tolerance to food protein. Mucosal Immunol 5:232\u2013239","journal-title":"Mucosal Immunol"},{"key":"1695_CR13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijbiomac.2017.10.101","volume":"110","author":"B Singh","year":"2018","unstructured":"Singh B, Maharjan S, Cho KH, Cui L, Park IK, Choi YJ, Cho CS (2018) Chitosan-based particulate systems for the delivery of mucosal vaccines against infectious diseases. Int J Biol Macromol 110:54\u201364","journal-title":"Int J Biol Macromol"},{"key":"1695_CR14","doi-asserted-by":"crossref","first-page":"643953","DOI":"10.3389\/fcimb.2021.643953","volume":"11","author":"H Boroumand","year":"2021","unstructured":"Boroumand H, Badie F, Mazaheri S, Seyedi ZS, Nahand JS, Nejati M, Baghi HB, Abbasi-Kolli M, Badehnoosh B, Ghandali M, Hamblin MR, Mirzaei H (2021) Chitosan-based nanoparticles against viral infections. Front Cell Infect Microbiol 11:643953\u2013643975","journal-title":"Front Cell Infect Microbiol"},{"key":"1695_CR15","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2147\/IJN.S238445","volume":"15","author":"S Renu","year":"2020","unstructured":"Renu S, Markazi AD, Dhakal S, Lakshmanappa YS, Shanmugasundaram R, Selvaraj RK, Renukaradhya GJ (2020) Oral deliverable mucoadhesive Chitosan-Salmonella subunit nanovaccine for layer chickens. Int J Nanomedicine 15:761\u2013777","journal-title":"Int J Nanomedicine"},{"key":"1695_CR16","doi-asserted-by":"crossref","first-page":"1269409","DOI":"10.3389\/fimmu.2023.1269409","volume":"14","author":"K Su","year":"2023","unstructured":"Su K, Wang Y, Yuan C, Zhang Y, Li Y, Li T, Song Q (2023) Intranasally inoculated bacterium-like particles displaying porcine epidemic diarrhea virus S1 protein induced intestinal mucosal immune response in mice. Front Immunol 14:1269409","journal-title":"Front Immunol"},{"key":"1695_CR17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.virusres.2016.06.002","volume":"226","author":"Q Song","year":"2016","unstructured":"Song Q, Stone S, Drebes D, Greiner LL, Dvorak CMT, Murtaugh MP (2016) Characterization of anti-porcine epidemic diarrhea virus neutralizing activity in mammary secretions. Virus Res 226:85\u201392","journal-title":"Virus Res"},{"key":"1695_CR18","volume":"293","author":"C Yuan","year":"2024","unstructured":"Yuan C, Lin Y, Wang Y, Zhang Y, Zhao X, Yuan H, Li T, Song Q (2024) Effects of porcine epidemic diarrhea virus infection on CD21+ B cells activation. Vet Microbiol 293:110087","journal-title":"Vet Microbiol"},{"key":"1695_CR19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.virusres.2016.08.005","volume":"226","author":"K Crawford","year":"2016","unstructured":"Crawford K, Lager KM, Kulshreshtha V, Miller LC, Faaberg KS (2016) Status of vaccines for porcine epidemic diarrhea virus in the United States and Canada. Virus Res 226:108\u2013116","journal-title":"Virus Res"},{"key":"1695_CR20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.vetmic.2016.11.029","volume":"206","author":"V Gerdts","year":"2017","unstructured":"Gerdts V, Zakhartchouk A (2017) Vaccines for porcine epidemic diarrhea virus and other swine coronaviruses. Vet Microbiol 206:45\u201351","journal-title":"Vet Microbiol"},{"key":"1695_CR21","volume":"290","author":"M Li","year":"2024","unstructured":"Li M, Sun X, Chen Y, Wang S, Li Q, Wang Y, Wang Y, Li R, Ding P, Zhang G (2024) Enhancing humoral and mucosal immune response of PED vaccine candidate by fusing S1 protein to nanoparticle multimerization. Vet Microbiol 290:110003","journal-title":"Vet Microbiol"},{"key":"1695_CR22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/irv.12697","volume":"14","author":"A Khalaj-Hedayati","year":"2020","unstructured":"Khalaj-Hedayati A, Chua CLL, Smooker P, Lee KW (2020) Nanoparticles in influenza subunit vaccine development: immunogenicity enhancement. Influenza Other Respir Viruses 14:92\u2013101","journal-title":"Influenza Other Respir Viruses"},{"key":"1695_CR23","doi-asserted-by":"crossref","first-page":"7760","DOI":"10.1021\/acsnano.0c04006","volume":"14","author":"G Chauhan","year":"2020","unstructured":"Chauhan G, Madou MJ, Kalra S, Chopra V, Ghosh D, Martinez-Chapa SO (2020) Nanotechnology for COVID-19: therapeutics and vaccine research. ACS Nano 14:7760\u20137782","journal-title":"ACS Nano"},{"key":"1695_CR24","volume":"264","author":"X Li","year":"2021","unstructured":"Li X, Xing R, Xu C, Liu S, Qin Y, Li K, Yu H, Li P (2021) Immunostimulatory effect of chitosan and quaternary chitosan: a review of potential vaccine adjuvants. Carbohydr Polym 264:118050","journal-title":"Carbohydr Polym"},{"key":"1695_CR25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.addr.2009.11.009","volume":"62","author":"M Amidi","year":"2010","unstructured":"Amidi M, Mastrobattista E, Jiskoot W, Hennink WE (2010) Chitosan-based delivery systems for protein therapeutics and antigens. Adv Drug Deliv Rev 62:59\u201382","journal-title":"Adv Drug Deliv Rev"},{"key":"1695_CR26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijpharm.2013.02.015","volume":"446","author":"A F\u00e0bregas","year":"2013","unstructured":"F\u00e0bregas A, Mi\u00f1arro M, Garc\u00eda-Montoya E, P\u00e9rez-Lozano P, Carrillo C, Sarrate R, S\u00e1nchez N, Tic\u00f3 JR, Su\u00f1\u00e9-Negre JM (2013) Impact of physical parameters on particle size and reaction yield when using the ionic gelation method to obtain cationic polymeric chitosan-tripolyphosphate nanoparticles. Int J Pharm 446:199\u2013204","journal-title":"Int J Pharm"},{"key":"1695_CR27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.msec.2018.07.001","volume":"92","author":"YB Sutar","year":"2018","unstructured":"Sutar YB, Telvekar VN (2018) Chitosan based copolymer-drug conjugate and its protein targeted polyelectrolyte complex nanoparticles to enhance the efficiency and specificity of low potency anticancer agent. Mater Sci Eng C Mater Biol Appl 92:393\u2013406","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"1695_CR28","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/molecules27010204","volume":"27","author":"X Gao","year":"2021","unstructured":"Gao X, Liu N, Wang Z, Gao J, Zhang H, Li M, Du Y, Gao X, Zheng A (2021) Development and optimization of chitosan nanoparticle-based intranasal vaccine carrier. Molecules 27:204\u2013225","journal-title":"Molecules"},{"key":"1695_CR29","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.carbpol.2016.05.092","volume":"151","author":"F R\u00e1zga","year":"2016","unstructured":"R\u00e1zga F, Vnukov\u00e1 D, N\u00e9methov\u00e1 V, Mazancov\u00e1 P, Lac\u00edk I (2016) Preparation of chitosan-TPP sub-micron particles: critical evaluation and derived recommendations. Carbohydr Polym 151:488\u2013499","journal-title":"Carbohydr Polym"},{"key":"1695_CR30","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3390\/polym14071443","volume":"14","author":"R Nunes","year":"2022","unstructured":"Nunes R, Serra AS, Simaite A, Sousa \u00c2 (2022) Modulation of Chitosan-TPP nanoparticle properties for plasmid DNA vaccines delivery. Polymers (Basel) 14:1443","journal-title":"Polymers (Basel)"},{"key":"1695_CR31","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3109\/02652048.2015.1073392","volume":"32","author":"E Cevher","year":"2015","unstructured":"Cevher E, Salomon SK, Makrakis A, Li XW, Brocchini S, Alpar HO (2015) Development of chitosan-pullulan composite nanoparticles for nasal delivery of vaccines: optimisation and cellular studies. J Microencapsul 32:755\u2013768","journal-title":"J Microencapsul"},{"key":"1695_CR32","volume":"294","author":"L Li","year":"2022","unstructured":"Li L, Sun X, Zhang H, Dong M, Wang J, Zhao S, Shang M, Wang X, Zhangsun H, Wang L (2022) Amphiphilic nano-delivery system based on modified-chitosan and ovalbumin: delivery and stability in simulated digestion. Carbohydr Polym 294:119779","journal-title":"Carbohydr Polym"},{"key":"1695_CR33","volume":"163","author":"Z Ding","year":"2023","unstructured":"Ding Z, Chen W, Jiang F, Mo M, Bi Y, Kong F (2023) Synthesis, characterization and in vitro digestion of folate conjugated chitosan-loaded proanthocyanidins nanoparticles. Food Res Int 163:112141","journal-title":"Food Res Int"},{"key":"1695_CR34","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","volume":"12","author":"N Lycke","year":"2012","unstructured":"Lycke N (2012) Recent progress in mucosal vaccine development: potential and limitations. Nat Rev Immunol 12:592\u2013605","journal-title":"Nat Rev Immunol"},{"key":"1695_CR35","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1002\/jbm.a.37198","volume":"109","author":"X Wu","year":"2021","unstructured":"Wu X, Farooq MA, Li T, Geng T, Kutoka PT, Wang B (2021) Cationic chitosan-modified silica nanoparticles for oral delivery of protein vaccine. J Biomed Mater Res A 109:2111\u20132119","journal-title":"J Biomed Mater Res A"},{"key":"1695_CR36","volume":"328","author":"P Ding","year":"2024","unstructured":"Ding P, Liu H, Zhu X, Chen Y, Zhou J, Chai S, Wang A, Zhang G (2024) Thiolated chitosan encapsulation constituted mucoadhesive nanovaccine confers broad protection against divergent influenza A viruses. Carbohydr Polym 328:121689","journal-title":"Carbohydr Polym"},{"key":"1695_CR37","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1007\/s12274-021-4012-9","volume":"15","author":"SH Zhuo","year":"2022","unstructured":"Zhuo SH, Wu JJ, Zhao L, Li WH, Zhao YF, Li YM (2022) A chitosan-mediated inhalable nanovaccine against SARS-CoV-2. Nano Res 15:4191\u20134200","journal-title":"Nano Res"},{"key":"1695_CR38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-4939-9167-9_6","volume":"1960","author":"KA Read","year":"2019","unstructured":"Read KA, Powell MD, Sreekumar BK, Oestreich KJ (2019) In vitro differentiation of effector CD4+ T helper cell subsets. Methods Mol Biol 1960:75\u201384","journal-title":"Methods Mol Biol"},{"key":"1695_CR39","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.558349","volume":"8","author":"S Renu","year":"2020","unstructured":"Renu S, Renukaradhya GJ (2020) Chitosan nanoparticle based mucosal vaccines delivered against infectious diseases of poultry and pigs. Front Bioeng Biotechnol 8:558349","journal-title":"Front Bioeng Biotechnol"},{"key":"1695_CR40","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.immuni.2016.02.004","volume":"44","author":"EC Carroll","year":"2016","unstructured":"Carroll EC, Jin L, Mori A, Mu\u00f1oz-Wolf N, Oleszycka E, Moran HBT, Mansouri S, McEntee CP, Lambe E, Agger EM, Andersen P, Cunningham C, Hertzog P, Fitzgerald KA, Bowie AG, Lavelle EC (2016) The vaccine adjuvant chitosan promotes cellular immunity via DNA sensor cGAS-STING-dependent induction of type I interferons. Immunity 44:597\u2013608","journal-title":"Immunity"},{"key":"1695_CR41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153041","volume":"11","author":"K Poonsuk","year":"2016","unstructured":"Poonsuk K, Gim\u00e9nez-Lirola LG, Zhang J, Arruda P, Chen Q, da Correa Silva Carrion L, Magtoto R, Pineyro P, Sarmento L, Wang C, Sun Y, Madson D, Johnson J, Yoon KJ, Zimmerman J, Main R (2016) Does circulating antibody play a role in the protection of piglets against porcine epidemic diarrhea virus? PLoS One 11:e0153041","journal-title":"PLoS ONE"},{"key":"1695_CR42","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.addr.2017.04.008","volume":"114","author":"JE Vela Ramirez","year":"2017","unstructured":"Vela Ramirez JE, Sharpe LA, Peppas NA (2017) Current state and challenges in developing oral vaccines. Adv Drug Deliv Rev 114:116\u2013131","journal-title":"Adv Drug Deliv Rev"},{"key":"1695_CR43","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/mi.2013.54","volume":"7","author":"S Cording","year":"2014","unstructured":"Cording S, Wahl B, Kulkarni D, Chopra H, Pezoldt J, Buettner M, Dummer A, Hadis U, Heimesaat M, Bereswill S, Falk C, Bode U, Hamann A, Fleissner D, Huehn J, Pabst O (2014) The intestinal micro-environment imprints stromal cells to promote efficient Treg induction in gut-draining lymph nodes. Mucosal Immunol 7:359\u2013368","journal-title":"Mucosal Immunol"},{"key":"1695_CR44","volume":"179","author":"Y Lee","year":"2021","unstructured":"Lee Y, Kamada N, Moon JJ (2021) Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome. Adv Drug Deliv Rev 179:114021","journal-title":"Adv Drug Deliv Rev"},{"key":"1695_CR45","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature22058","volume":"544","author":"K Moor","year":"2017","unstructured":"Moor K, Diard M, Sellin ME, Felmy B, Wotzka SY, Toska A, Bakkeren E, Arnoldini M, Bansept F, Co AD, V\u00f6ller T, Minola A, Fernandez-Rodriguez B, Agatic G, Barbieri S, Piccoli L, Casiraghi C, Corti D, Lanzavecchia A, Regoes RR, Loverdo C, Stocker R, Brumley DR, Hardt WD, Slack E (2017) High-avidity IgA protects the intestine by enchaining growing bacteria. Nature 544:498\u2013502","journal-title":"Nature"},{"key":"1695_CR46","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jconrel.2020.01.033","volume":"321","author":"S Bakshi","year":"2020","unstructured":"Bakshi S, Sanz Garcia R, Van der Weken H, Tharad A, Pandey S, Juarez P, Virdi V, Devriendt B, Cox E, Depicker A (2020) Evaluating single-domain antibodies as carriers for targeted vaccine delivery to the small intestinal epithelium. J Control Release 321:416\u2013429","journal-title":"J Control Release"},{"key":"1695_CR47","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1177\/0300985820932140","volume":"57","author":"YM Chen","year":"2020","unstructured":"Chen YM, Helm ET, Gabler N, Hostetter JM, Burrough ER (2020) Alterations in intestinal innate mucosal immunity of weaned pigs during porcine epidemic diarrhea virus infection. Vet Pathol 57:642\u2013652","journal-title":"Vet Pathol"},{"key":"1695_CR48","doi-asserted-by":"crossref","first-page":"7844","DOI":"10.1039\/C9FO01650C","volume":"10","author":"K Wang","year":"2019","unstructured":"Wang K, Cao G, Zhang H, Li Q, Yang C (2019) Effects of Clostridium butyricum and Enterococcus faecalis on growth performance, immune function, intestinal morphology, volatile fatty acids, and intestinal flora in a piglet model. Food Funct 10:7844\u20137854","journal-title":"Food Funct"}],"container-title":["Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13567-025-01695-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13567-025-01695-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13567-025-01695-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:03:01Z","timestamp":1769101381000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13567-025-01695-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1695"],"URL":"https:\/\/doi.org\/10.1186\/s13567-025-01695-6","relation":{},"ISSN":["1297-9716"],"issn-type":[{"value":"1297-9716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"6 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was ethically approved by the Hebei Agricultural University (China) Animal Welfare and Ethical Review Board (Permit Number: 1820026). The experiments were conducted according to the Guidelines for the Care and Use of Laboratory Animals of Hebei Agricultural University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"14"}}